# Concerto Biosciences, Inc. — Form D/A

Concerto Biosciences, Inc. of ALLSTON, MA, a company, filed a Form D amendment with the SEC on 2022-06-16. The offering totals $24.5M, of which $24.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-06-16
- Form: D/A
- Accession: 0001918491-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $24.5M
- Amount sold: $24.5M
- Investors: 37
- Date of first sale: 2022-03-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-438545

## Issuer

- Name: Concerto Biosciences, Inc.
- CIK: 0001918491
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 127 WESTERN AVE, ALLSTON, MA, 02134
- Phone: 617-544-7044

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Cheri Ackerman | Director | Allston, MA |
| Bernardo Cervantes | Director | Allston, MA |
| Jared Kehe | Director | Allston, MA |
| Sarah Luppino | Director | Allston, MA |
| Vera Schroeder | Director | LONG ISLAND CITY, NY |
| Cheri Ackerman | Executive Officer | Allston, MA |
| Bernardo Cervantes | Executive Officer | Allston, MA |
| Jared Kehe | Executive Officer | Allston, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-03-23](https://search.stillhousedata.com/formd/0001918491-22-000001) | D | $24.5M | $16.0M |

## More

- [CIK 1918491 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1918491&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001918491-22-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.